We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
Travelers Companies
TRV
$81.2B
| $297K | 0.01% |
2,985
+9
| +0.3% | +$920 |
2014 Q1
6 quarters
|
|
427
DELISTED
CHUBB CORPORATION
CB
| $296K | 0.01% |
2,416
-106
| -4% | -$13K |
2013 Q2
9 quarters
|
|
428
Southern Company
SO
$104B
| $294K | 0.01% |
6,574
-738
| -10% | -$32.4K |
2013 Q2
9 quarters
|
|
429
Target
TGT
$70B
| $294K | 0.01% |
3,735
+367
| +11% | +$29.3K |
2013 Q2
9 quarters
|
|
430
RLI Corp
RLI
$5.58B
| $293K | 0.01% |
10,948
| – | – |
2014 Q4
3 quarters
|
|
431
Sasol
SSL
$10.4B
| $292K | 0.01% |
10,507
-1,639
| -13% | -$52.5K |
2014 Q2
5 quarters
|
|
|
RHT
432
DELISTED
Red Hat Inc
RHT
| $292K | 0.01% |
4,060
| – | – |
2014 Q1
6 quarters
|
|
433
Xylem
XYL
$24.2B
| $289K | 0.01% |
8,797
-400
| -4% | -$13.5K |
2013 Q2
9 quarters
|
|
|
RAI
434
DELISTED
Reynolds American Inc
RAI
| $289K | 0.01% |
6,539
+551
| +9% | +$22.9K |
2015 Q2
1 quarter
|
|
435
General Dynamics
GD
$92.7B
| $285K | 0.01% |
2,065
+622
| +43% | +$90K |
2015 Q2
1 quarter
|
|
436
NOV
NOV
$6.75B
| $285K | 0.01% |
7,576
| – | – |
2013 Q2
9 quarters
|
|
437
MetLife
MET
$64.4B
| $284K | 0.01% |
6,760
+27
| +0.4% | +$1.26K |
2013 Q4
7 quarters
|
|
438
DELISTED
NuStar Energy L.P.
NS
| $282K | 0.01% |
6,287
| – | – |
2013 Q2
9 quarters
|
|
439
CSX Corp
CSX
$89.9B
| $277K | 0.01% |
30,936
-7,470
| -19% | -$73.3K |
2013 Q4
7 quarters
|
|
|
RTN
440
DELISTED
Raytheon Company
RTN
| $277K | 0.01% |
2,537
-5
| -0.2% | -$522 |
2013 Q4
7 quarters
|
|
|
ESES
441
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
| $277K | 0.01% |
80,667
+6,500
| +9% | +$25.5K |
2015 Q2
1 quarter
|
|
442
AptarGroup
ATR
$7.91B
| $274K | 0.01% |
4,154
| – | – |
2013 Q2
9 quarters
|
|
443
Paychex
PAYX
$39.2B
| $274K | 0.01% |
5,750
+148
| +3% | +$6.9K |
2014 Q1
6 quarters
|
|
444
iShares Russell 3000 ETF
IWV
$20.1B
| $273K | 0.01% |
2,397
+1
| +0% | +$121 |
2013 Q4
7 quarters
|
|
445
DELISTED
Spectra Energy Corp Wi
SE
| $273K | 0.01% |
10,400
+100
| +1% | +$2.91K |
2013 Q2
9 quarters
|
|
446
Banco Macro
BMA
$4.06B
| $270K | 0.01% |
7,033
-1,205
| -15% | -$53.9K |
2015 Q1
2 quarters
|
|
447
Dominion Energy
D
$56B
| $270K | 0.01% |
3,830
-110
| -3% | -$7.73K |
2013 Q4
7 quarters
|
|
448
Clorox
CLX
$10.4B
| $267K | 0.01% |
2,310
-27
| -1% | -$3.03K |
2014 Q2
5 quarters
|
|
449
Annaly Capital Management
NLY
$13.8B
| $263K | 0.01% |
6,667
-1,250
| -16% | -$50K |
2013 Q3
8 quarters
|
|
450
State Street Technology Select Sector SPDR ETF
XLK
$121B
| $263K | 0.01% |
13,328
+24
| +0.2% | +$494 |
2014 Q1
6 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.